Header Logo

JORGE CASTILLO

TitleAssistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
Address1504 TAUB LOOP
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Durot E, Kanagaratnam L, Zanwar S, Kaufman A, D'Sa S, Toussaint E, Roos-Weil D, Alcoceba M, Vos JMI, Michallet AS, Talaulikar D, Kastritis E, Khwaja J, Treon SP, Garcia-Sanz R, Morel P, Munoz J, Castillo JJ, Kapoor P, Delmer A. Autologous and Allogeneic Stem-Cell Transplantation for Transformed Waldenstr?m Macroglobulinemia. Am J Hematol. 2024 Nov 26. PMID: 39588555.
      Citations:    Fields:    
    2. Stanchina MD, Montoya S, Danilov AV, Castillo JJ, Alencar AJ, Chavez JC, Cheah CY, Chiattone C, Wang Y, Thompson M, Ghia P, Taylor J, Alderuccio JP. Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia. Nat Rev Clin Oncol. 2024 Dec; 21(12):867-887. PMID: 39487228.
      Citations:    Fields:    Translation:HumansCells
    3. Valcarcel B, Schonfeld SJ, Shiels MS, Castillo JJ, Morton LM. Survival outcomes in diffuse large B-cell lymphoma patients with and without HIV in the United States from 2001 to 2016: a population-based analysis. Haematologica. 2024 Oct 31. PMID: 39479866.
      Citations:    Fields:    
    4. Narasimhan S, Galetta KM, Castillo JJ, Bhattacharyya S. Paraneoplastic myelitis associated with Waldenstr?m macroglobulinemia responsive to treatment with ibrutinib - venetoclax: A case report. eNeurologicalSci. 2024 Dec; 37:100527. PMID: 39309451; PMCID: PMC11415854.
      Citations:    
    5. Cabrera ME, Pe?a C, Vega V, Rojas H, Pizarro A, Rojas C, Calderon S, Oliva J, Hales C, Rojas B, Intriago M, Capurro M, Gonzalez ML, Castillo JJ. Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy. Cancer Rep (Hoboken). 2024 Sep; 7(9):e2126. PMID: 39307921; PMCID: PMC11416906.
      Citations:    Fields:    Translation:Humans
    6. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2024 update on the diagnosis, risk-stratification, and management. Am J Hematol. 2024 Oct; 99(10):2002-2015. PMID: 38957951.
      Citations:    Fields:    Translation:HumansCells
    7. Bibas M, Sarosiek S, Castillo JJ. Waldenstr?m Macroglobulinemia - A State-of-the-Art Review: Part 1: Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Risk Stratification, and Clinical Problems. Mediterr J Hematol Infect Dis. 2024; 16(1):e2024061. PMID: 38984103; PMCID: PMC11232678.
      Citations:    
    8. Zanwar S, Le-Rademacher J, Durot E, D'Sa S, Abeykoon JP, Mondello P, Kumar S, Sarosiek S, Paludo J, Chhabra S, Cook JM, Parrondo R, Dispenzieri A, Gonsalves WI, Muchtar E, Ailawadhi S, Kyle RA, Rajkumar SV, Delmer A, Fonseca R, Gertz MA, Treon SP, Ansell SM, Castillo JJ, Kapoor P. Simplified Risk Stratification Model for Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2024 Jul 20; 42(21):2527-2536. PMID: 38788183; PMCID: PMC11268554.
      Citations: 2     Fields:    Translation:Humans
    9. Ramirez-Gamero A, Mart?nez-Cordero H, Beltr?n BE, Florindez J, Malpica L, Castillo JJ. Plasmablastic lymphoma: 2024 update on diagnosis, risk stratification, and management. Am J Hematol. 2024 08; 99(8):1586-1594. PMID: 38767403.
      Citations:    Fields:    Translation:Humans
    10. Sarosiek S, Castillo JJ. Optimizing BTK Inhibition in Waldenstr?m Macroglobulinemia. J Natl Compr Canc Netw. 2024 05; 22(4). PMID: 38754469.
      Citations:    Fields:    Translation:Humans
    11. Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garc?a-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fern?ndez De Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trnen? M, Minnema MC, Buske C, Leblond V, Treon SP, Trotman J, Wu B, Yu Y, Shen Z, Chan WY, Schneider J, Allewelt H, Cohen A, Dimopoulos MA. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenstr?m macroglobulinemia. Blood Adv. 2024 04 09; 8(7):1639-1650. PMID: 38315878; PMCID: PMC11006814.
      Citations: 1     Fields:    Translation:Humans
    12. Itchaki G, Jarhovsky O, Castillo JJ, Hassan H, Gatt ML, Leiba M, Raanani P, Gertz MA, Vaxman I. Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review. Leuk Lymphoma. 2024 Jul; 65(7):943-949. PMID: 38501758.
      Citations:    Fields:    Translation:Humans
    13. Sarosiek S, Castillo JJ. Waldenstr?m Macroglobulinemia: Targeted Agents Taking Center Stage. Drugs. 2024 Jan; 84(1):17-25. PMID: 38055179.
      Citations: 1     Fields:    Translation:Humans
    14. AlJabban A, Paik H, Aster JC, Berliner N, Brouillard J, Brown JR, Burns KH, Castillo JJ, Card J, Dal Cin P, DeAngelo DJ, Dorfman DM, Ebert BL, Garcia JS, Jacobson CA, Lakhani H, Laubach JP, Ligon AH, Lindeman NI, Lindsley RC, Lovitch SB, Luskin MR, Morgan EA, Nowak A, Petrides A, Pinkus GS, Pozdnyakova O, Steensma DP, Stone RM, Weinberg OK, Winer ES, Kim AS. Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing. JCO Oncol Pract. 2024 Feb; 20(2):220-227. PMID: 37683132.
      Citations:    Fields:    Translation:Humans
    15. Leung BW, Fay CJ, Said JT, Sheets AR, Lian CG, Brown JR, Castillo JJ, Sarosiek S, Flynn C, LeBoeuf NR. Localized upper extremity edema secondary to Bruton's tyrosine kinase inhibition. Leuk Lymphoma. 2023 12; 64(12):2047-2050. PMID: 37671695.
      Citations:    Fields:    Translation:Humans
    16. Bustoros M, Gribbin C, Castillo JJ, Furman R. Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 Aug; 37(4S):e1-e13. PMID: 37574332.
      Citations:    Fields:    
    17. Dimopoulos MA, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, Wahlin BE, Garcia-Sanz R, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Fern?ndez de Larrea C, Belada D, Libby E, Matous J, Motta M, Siddiqi T, Tani M, Trnen? M, Buske C, Leblond V, Treon SP, Trotman J, Chan WY, Schneider J, Allewelt H, Patel S, Cohen A, Tam CS, Minnema MC. Zanubrutinib Versus Ibrutinib in Symptomatic Waldenstr?m Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. J Clin Oncol. 2023 Nov 20; 41(33):5099-5106. PMID: 37478390; PMCID: PMC10666987.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    18. Candelaria M, Villela L, Torres-Viera MA, Pe?a C, Roa M, Zambrano D, Colunga-Pedraza PRR, Robles-Rodr?guez A, P?rez-Jacobo F, Oliver AC, Irigo?n MV, Idrobo H, Paredes SR, Oliday R, Castro D, Monta?o-Figueroa E, Perini GF, Fern?ndez-Aguila JD, Malpica LE, Beltran BE, Castillo JJ, Baena R. Real-world experience in older patients with diffuse large B-cell lymphoma treated in Latin America: A study by the Latin American study group of lymphoproliferative disorders (GELL). J Geriatr Oncol. 2023 09; 14(7):101565. PMID: 37419788.
      Citations:    Fields:    Translation:Humans
    19. Sarosiek S, Treon SP, Branagan AR, Castillo JJ. Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenstr?m's Macroglobulinemia? J Clin Oncol. 2023 08 20; 41(24):4059-4060. PMID: 37348023.
      Citations:    Fields:    Translation:Humans
    20. Castillo JJ, Sarosiek S, Kapoor P. Waldenstr?m Macroglobulinemia: A Myriad of Effective Treatment Options, but Still Work to be Done. Hematol Oncol Clin North Am. 2023 08; 37(4):xiii-xiv. PMID: 37211493.
      Citations:    Fields:    Translation:Humans
    21. Sarosiek S, Castillo JJ. Novel Agents in Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2023 08; 37(4):751-760. PMID: 37198054.
      Citations: 2     Fields:    Translation:Humans
    22. Castro D, Valcarcel B, Runciman T, Huerta-Collado Y, Paredes S, Beltran BE, Castillo JJ, Malpica L. The prognostic role of red cell distribution width on all-cause and cause-specific outcomes in peripheral T-cell lymphoma: a retrospective cohort study. Leuk Lymphoma. 2023 Jul-Aug; 64(7):1225-1233. PMID: 37132428.
      Citations:    Fields:    
    23. Sarosiek S, Gustine JN, Flynn CA, Leventoff C, Little M, White T, Meid K, Treon SP, Castillo JJ. Dose reductions in patients with Waldenstr?m macroglobulinaemia treated with ibrutinib. Br J Haematol. 2023 06; 201(5):897-904. PMID: 36626914.
      Citations: 1     Fields:    Translation:Humans
    24. Castillo JJ, Buske C, Trotman J, Sarosiek S, Treon SP. Bruton tyrosine kinase inhibitors in the management of Waldenstr?m macroglobulinemia. Am J Hematol. 2023 02; 98(2):338-347. PMID: 36415104; PMCID: PMC10107762.
      Citations: 3     Fields:    Translation:Humans
    25. Hess BT, Giri A, Park Y, Patel KK, Link BK, Nowakowski GS, Maliske SM, Fortin S, Chavez JC, Saeed H, Hill BT, Mejia Garcia AV, Maddocks KJ, Hanel W, Wagner-Johnston ND, Messmer MR, Kahl BS, Watkins M, Alderuccio JP, Lossos IS, Nathan S, Orellana-Noia VM, Portell CA, Landsburg DJ, Ayers EC, Castillo JJ. Outcomes of patients with limited-stage plasmablastic lymphoma: A multi-institutional retrospective study. Am J Hematol. 2023 02; 98(2):300-308. PMID: 36588409; PMCID: PMC10107934.
      Citations: 2     Fields:    Translation:Humans
    26. Cabrera ME, Pe?a C, Leon P, Lois V, Rojas H, Vega V, Pizarro A, Calderon S, Rojas C, Aspillaga A, Gonzalez ML, Intriago M, Rojas B, Hales C, Oliva J, Romero M, Capurro M, Castillo JJ. Diffuse Large B-Cell Lymphoma in Chile: The Impact of Combined CHOP Plus Rituximab in the Public Health System. JCO Glob Oncol. 2022 11; 8:e2200165. PMID: 36351213; PMCID: PMC10166504.
      Citations:    Fields:    Translation:HumansPHPublic Health
    27. Jelinek T, Bezdekova R, Zihala D, Sevcikova T, Anilkumar Sithara A, Pospisilova L, Sevcikova S, Polackova P, Stork M, Knechtova Z, Venglar O, Kapustova V, Popkova T, Muronova L, Chyra Z, Hrdinka M, Simicek M, Garc?s JJ, Puig N, Cedena MT, Jurczyszyn A, Castillo JJ, Penka M, Radocha J, Mateos MV, San-Miguel JF, Paiva B, Pour L, Rihova L, Hajek R. More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma. J Clin Oncol. 2023 03 01; 41(7):1383-1392. PMID: 36315921; PMCID: PMC9995102.
      Citations: 5     Fields:    Translation:HumansCells
    28. Riva E, Duarte PJ, Valc?rcel B, Remaggi G, Murrieta I, Corzo A, Del Carpio D, Pe?a C, V?squez J, Bove V, Teixeira L, Fleury-Perini G, Yantorno S, Sam?nez C, Lopresti S, Altamirano M, Villela L, Ruiz-Arguelles GJ, Ruiz-Delgado GJ, Monta?o E, Verri V, Zamora P?rez E, P?rez Jacobo F, Idrobo H, Mart?nez-Cordero H, Beltran BE, Ram?rez J, Castillo JJ, Malpica Castillo LE. Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study. JCO Glob Oncol. 2022 08; 8:e2100380. PMID: 35939775; PMCID: PMC9470138.
      Citations:    
    29. Castillo JJ, Sarosiek S, Flynn CA, Leventoff C, Little M, White T, Meid K, Treon SP. A pilot study on dasatinib in patients with Waldenstr?m macroglobulinemia progressing on ibrutinib. EJHaem. 2022 Aug; 3(3):927-929. PMID: 36051045; PMCID: PMC9421949.
      Citations:    
    30. Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management. Am J Hematol. 2022 07; 97(7):951-965. PMID: 35472248.
      Citations:    Fields:    Translation:HumansCells
    31. Branagan AR, Gustine JN, Sarosiek S, Flynn CA, Meid K, Leventoff C, White T, Guerrera ML, Xu L, Kofides A, Tsakmaklis N, Munshi M, Demos M, Patterson CJ, Liu X, Yang G, Hunter ZR, Treon SP, Castillo JJ. Natural history of Waldenstr?m macroglobulinemia following acquired resistance to ibrutinib monotherapy. Haematologica. 2022 05 01; 107(5):1163-1171. PMID: 34162182; PMCID: PMC9052900.
      Citations:    Fields:    Translation:Humans
    32. Sermer D, Branagan AR, Sarosiek S, Treon SP, Castillo JJ. Zanubrutinib for the treatment of adults with Waldenstrom macroglobulinemia. Expert Rev Anticancer Ther. 2022 05; 22(5):471-478. PMID: 35404729.
      Citations:    Fields:    Translation:Humans
    33. Alderuccio JP, Arcaini L, Watkins MP, Beaven AW, Shouse G, Epperla N, Spina M, Stefanovic A, Sandoval-Sus J, Torka P, Alpert AB, Olszewski AJ, Kim SH, Hess B, Gaballa S, Ayyappan S, Castillo JJ, Voorhees TJ, Saba R, Chowdhury SM, Vargas F, Reis IM, Kwon D, Alexander JS, Zhao W, Edwards D, Martin P, Cencini E, Kamdar M, Link BK, Logothetis CN, Herrera AF, Friedberg JW, Kahl BS, Luminari S, Lossos IS, Argnani L, Zinzani PL. An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood Adv. 2022 04 12; 6(7):2035-2044. PMID: 35196377; PMCID: PMC9006265.
      Citations: 1     Fields:    Translation:Humans
    34. Tahri S, Mouhieddine TH, Redd R, Lampe L, Nilsson KI, El-Khoury H, Su NK, Nassar AH, Adib E, Bindra G, Abou Alaiwi S, Trippa L, Steensma DP, Castillo JJ, Treon SP, Ghobrial IM, Sperling AS. Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenstr?m macroglobulinemia. Blood Adv. 2022 04 12; 6(7):2230-2235. PMID: 34847227; PMCID: PMC9006277.
      Citations:    Fields:    Translation:Humans
    35. Sermer D, Sarosiek S, Branagan AR, Treon SP, Castillo JJ. SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenstr?m Macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2022 08; 22(8):547-556. PMID: 35339405.
      Citations:    Fields:    Translation:Humans
    36. Castillo JJ. A British view on the management of Waldenstr?m macroglobulinemia. Br J Haematol. 2022 04; 197(2):133-134. PMID: 35138638.
      Citations:    Fields:    Translation:Humans
    37. Mendoza R, Castro D, Paredes S, Miranda RN, Castillo JJ, Torres-Cabala C, Qui?ones MP, Beltr?n BE, Mois?s C, S?nchez G. Primary cutaneous Epstein-Barr virus-positive B-cell lymphoid proliferation with features of diffuse large B-cell lymphoma and mucocutaneous ulcer: a diagnostic dilemma. Int J Dermatol. 2023 02; 62(2):e87-e90. PMID: 35064673.
      Citations:    Fields:    
    38. Marinov N, Roa M, Castillo JJ, Matutes E, Cabrera ME. Epidemiology of chronic lymphocytic leukemia in Chilean and Amerindian population in Chile. Leuk Lymphoma. 2022 05; 63(5):1137-1143. PMID: 34886754.
      Citations:    Fields:    Translation:Humans
    39. Allan JN, Siddiqi T, Advani RH, Branagan AR, Davids MS, Furman RR, Castillo JJ, Meid K, Leventoff C, White TP, Flynn CA, Sarosiek S, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Treon SP. Venetoclax in Previously Treated Waldenstr?m Macroglobulinemia. J Clin Oncol. 2022 01 01; 40(1):63-71. PMID: 34793256; PMCID: PMC8683218.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    40. Malpica L, Enriquez DJ, Idrobo H, Valcarcel B, Villela L, Ramos JC, Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL), Castro D, Oviedo-Pecho R, Pe?a C, Fiad L, Prates M, Paredes A, S?nchez G, Mois?s C, Castillo JJ, Biglione M, Beltran BE. An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2022 02; 63(2):315-325. PMID: 34585997.
      Citations:    Fields:    Translation:HumansCells
    41. Branagan AR, O'Donnell E, Raje N, Yee AJ, Castillo JJ, Meid K, Gustine JN, Leventoff C, White T, Flynn CA, Sarosiek S, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Xu L, Yang G, Patterson CJ, Hunter ZR, Treon SP. Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia. Leukemia. 2022 02; 36(2):532-539. PMID: 34531537; PMCID: PMC8807393.
      Citations: 4     Fields:    Translation:Humans
    42. Sarosiek S, Treon SP, Castillo JJ. How to Sequence Therapies in Waldenstr?m Macroglobulinemia. Curr Treat Options Oncol. 2021 08 23; 22(10):92. PMID: 34426943.
      Citations: 2     Fields:    Translation:Humans
    43. LaMacchia J, Pozdnyakova O, Castillo JJ, Flynn CA, Sarosiek S, Treon SP. Plasmablastic lymphoma transformation in a patient with Waldenstr?m macroglobulinemia treated with ibrutinib. Br J Haematol. 2021 11; 195(3):466-468. PMID: 34355802.
      Citations:    Fields:    Translation:Humans
    44. Castillo JJ, Lamacchia J, Silver J, Flynn CA, Sarosiek S. Complete response to pembrolizumab and radiation in a patient with HIV-negative, EBV-positive plasmablastic lymphoma. Am J Hematol. 2021 10 01; 96(10):E390-E392. PMID: 34260089.
      Citations:    Fields:    Translation:HumansCells
    45. Branagan AR, Kofides A, Hunter ZR, Xu L, Tsakmaklis N, Demos MG, Munshi M, Liu X, Guerrera ML, Leventoff CR, White TP, Flynn CA, Meid K, Patterson CJ, Yang G, Sarosiek S, Castillo JJ, Treon SP, Gustine JN. Diagnostic Next-generation Sequencing Frequently Fails to Detect MYD88L265P in Waldenstr?m Macroglobulinemia. Hemasphere. 2021 Aug; 5(8):e624. PMID: 34291197; PMCID: PMC8288895.
      Citations: 3     
    46. Malpica L, Enriquez DJ, Idrobo H, Altamirano M, Sandival-Ampuero G, Aviles-Perez U, Meza K, Aguirre-Martinez L, Maradei JL, Soto P, Cabrera ME, Di Stefano M, Choque JA, Von Glasenapp A, Torres-Viera MA, Ramos JC, Villela L, Castro DA, Pe?a C, Fiad L, Prates M, Otero V, Biglione M, Cristaldo N, Guanchiale L, Vi?uela JL, Paredes SR, Riva E, Noboa A, Candelaria M, Valvert F, Castillo JJ, Beltran BE. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos. JCO Glob Oncol. 2021 07; 7:1151-1166. PMID: 34270330; PMCID: PMC8457808.
      Citations: 1     Fields:    Translation:Humans
    47. Castillo JJ, Beltran BE, Malpica L, Marques-Piubelli ML, Miranda RN. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK?+?LBCL): a systematic review of clinicopathological features and management. Leuk Lymphoma. 2021 12; 62(12):2845-2853. PMID: 34151703.
      Citations:    Fields:    Translation:Humans
    48. Martz CA, Jarbeau JF, Castillo JJ, Fisher DC, Nohria A. Medical Management of Hemodynamically Unstable Sinoatrial Node Dysfunction in a Patient With Intracardiac Lymphoma. JACC CardioOncol. 2021 Jun; 3(2):326-329. PMID: 34396343; PMCID: PMC8352225.
      Citations:    
    49. Mozessohn L, Zhang L, Odejide OO, Chen R, Buckstein R, Soiffer RJ, Driver JA, Abel GA, Castillo JJ. Prognostic value of disease risk score versus gait speed in older adults with lymphoma. Leuk Lymphoma. 2021 12; 62(12):2882-2889. PMID: 34114930.
      Citations:    Fields:    Translation:Humans
    50. Branagan AR, Demos MG, Hunter ZR, Xu L, Tsakmaklis N, Kofides A, Munshi M, Liu X, Guerrera ML, Leventoff CR, White TP, Flynn CA, Meid K, Patterson CJ, Yang G, Sarosiek S, Castillo JJ, Treon SP, Gustine JN. Cell-free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenstr?m macroglobulinemia. Am J Hematol. 2021 07 01; 96(7):E250-E253. PMID: 33819355.
      Citations: 3     Fields:    Translation:Humans
    51. Castillo JJ, Callander NS, Baljevic M, Sborov DW, Kumar S. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance. Am J Hematol. 2021 07 01; 96(7):846-853. PMID: 33709474; PMCID: PMC8252623.
      Citations: 1     Fields:    Translation:HumansAnimals
    52. Branagan AR, Gustine JN, Xu L, Yang G, Liu X, Kofides A, Tsakmaklis N, Munshi M, Demos M, Guerrera ML, Meid K, Patterson CJ, Sarosiek S, Hunter ZR, Castillo JJ, Treon SP. Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenstr?m macroglobulinaemia. Br J Haematol. 2021 08; 194(4):730-733. PMID: 33713429; PMCID: PMC9113056.
      Citations: 4     Fields:    Translation:Humans
    53. Sarosiek S, Treon SP, Castillo JJ. Reducing treatment toxicity in Waldenstr?m macroglobulinemia. Expert Opin Drug Saf. 2021 Jun; 20(6):669-676. PMID: 33645373.
      Citations:    Fields:    Translation:Humans
    54. Branagan AR, Lei M, Treon SP, Castillo JJ. Clinical application of genomics in Waldenstr?m macroglobulinemia. Leuk Lymphoma. 2021 08; 62(8):1805-1815. PMID: 33569985.
      Citations:    Fields:    Translation:Humans
    55. Pachas C, Huerta Y, Lalupu K, Mendoza R, Castillo JJ, Castro D, Beltr?n B, Qui?ones MDP. Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma. Leuk Res. 2021 03; 102:106513. PMID: 33561632.
      Citations: 1     Fields:    Translation:Humans
    56. Castillo JJ, Treon SP. Management of Waldenstr?m macroglobulinemia in 2020. Hematology Am Soc Hematol Educ Program. 2020 12 04; 2020(1):372-379. PMID: 33275726; PMCID: PMC7727571.
      Citations: 6     Fields:    Translation:Humans
    57. Abeykoon JP, Zanwar S, King R, Advani RH, Palomba ML, Ansell SM, Gertz MA, Kapoor P, Castillo JJ, Gustine JN, Mein K, Flynn CA, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Yang G, Hunter ZR, Treon SP. Partial response or better at six?months is prognostic of superior progression-free survival in Waldenstr?m macroglobulinaemia patients treated with ibrutinib. Br J Haematol. 2021 02; 192(3):542-550. PMID: 33207010; PMCID: PMC8937605.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    58. Advani RH, Branagan AR, Buske C, Dimopoulos MA, Minnema MC, Owen RG, Palomba ML, Talaulikar D, Tedeschi A, Trotman J, Varettoni M, Vos JM, Kastritis E, Castillo JJ, D'Sa S, Kersten MJ, Leblond V, Treon SP. Consensus treatment recommendations from the tenth International Workshop for Waldenstr?m Macroglobulinaemia. Lancet Haematol. 2020 Nov; 7(11):e827-e837. PMID: 33091356.
      Citations: 24     Fields:    Translation:Humans
    59. Tam CS, Opat S, D'Sa S, Jurczak W, Lee HP, Cull G, Owen RG, Marlton P, McCarthy H, Mulligan S, Tedeschi A, Castillo JJ, Czyz J, Libby E, Matous JV, Motta M, Siddiqi T, Trneny M, Minnema MC, Trotman J, Chan WY, Schneider J, Ro S, Cohen A, Huang J, Dimopoulos M, Wahlin BE, Sanz RG, Fern?ndez de Larrea C, Belada D, Tani M, Buske C, Leblond V. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstr?m macroglobulinemia: the ASPEN study. Blood. 2020 10 29; 136(18):2038-2050. PMID: 32731259; PMCID: PMC7596850.
      Citations: 63     Fields:    Translation:HumansCTClinical Trials
    60. Jim?nez C, Xu L, Tsakmaklis N, Demos MG, Kofides A, Chan GG, Guerrera ML, Chen JG, Liu X, Munshi M, Patterson CJ, Yang G, Castillo JJ, Treon SP, Hunter ZR. Comparative genomics of CXCR4MUT and CXCR4WT single cells in Waldenstr?m's macroglobulinemia. Blood Adv. 2020 09 22; 4(18):4550-4553. PMID: 32956451; PMCID: PMC7509875.
      Citations: 2     Fields:    Translation:Humans
    61. Branagan AR, Palomba ML, Advani R, Treon SP, Meid K, Gustine J, Yang G, Xu L, Liu X, Patterson CJ, Hunter ZR, Laubach JP, Ghobrial IM, Castillo JJ. Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2021 02 20; 39(6):565-575. PMID: 32931398; PMCID: PMC8078354.
      Citations: 29     Fields:    Translation:Humans
    62. Castillo JJ, Meid K, Flynn CA, Chen J, Demos MG, Guerrera ML, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Yang G, Hunter Z, Treon SP. Ixazomib, dexamethasone, and rituximab in treatment-naive patients with Waldenstr?m macroglobulinemia: long-term follow-up. Blood Adv. 2020 08 25; 4(16):3952-3959. PMID: 32822482; PMCID: PMC7448596.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    63. Jurczyszyn A, Waszczuk-Gajda A, Castillo JJ, Krawczyk K, Stork M, Pour L, Usnarska-Zubkiewicz L, Potoczek S, Hus I, Davila Valls J, Hari P, Chhabra S, Gentile M, Mikala G, Varga G, Chim CS, Fiala M, Vij R, Schutz N, Rodzaj M, Porowska A, Vesole DH, Druzd-Sitek A, Walewski J, Nooka AK. Primary refractory multiple myeloma: a real-world experience with 85 cases. Leuk Lymphoma. 2020 12; 61(12):2868-2875. PMID: 32623944.
      Citations: 1     Fields:    Translation:Humans
    64. Aguilar C, Laberiano C, Beltran B, Diaz C, Castillo JJ, Taype-Rondan A. Clinicopathologic characteristics and survival of patients with primary effusion lymphoma. Leuk Lymphoma. 2020 09; 61(9):2093-2102. PMID: 32449626.
      Citations: 4     Fields:    Translation:HumansCells
    65. Treon SP, Castillo JJ, Skarbnik AP, Soumerai JD, Ghobrial IM, Guerrera ML, Meid K, Yang G. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020 05 21; 135(21):1912-1915. PMID: 32302379; PMCID: PMC7243149.
      Citations: 131     Fields:    Translation:HumansCellsPHPublic Health
    66. Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Response and Survival Outcomes to Ibrutinib Monotherapy for Patients With Waldenstr?m Macroglobulinemia on and off Clinical Trials. Hemasphere. 2020 Jun; 4(3):e363. PMID: 32647793; PMCID: PMC7306303.
      Citations: 3     
    67. Torres MA, Otero V, Fiad L, Cabrera ME, Idrobo H, Rojas C, Malpica L, Sotomayor EM, Castillo JJ, Latin American Group of Lymphoproliferative Disorders (Grupo de Estudio Latinoamericano de Linfoprol, Beltr?n BE, Villela L, Pe?a C, Le?n P, Castro DA, Paredes S, Perdomo I, Abello V, Ramirez-Ibarg?en A, Candelaria M, P?rez-Jacobo F, Monta?o-Figueroa E, Best C, Gom?z-De Leon A, G?mez-Almaguer D, Ruiz-Arg?elles G, Hern?ndez-Hern?ndez J. A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL). Clin Lymphoma Myeloma Leuk. 2020 10; 20(10):637-646. PMID: 32513598.
      Citations: 1     Fields:    Translation:HumansCells
    68. Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grzasko N, Radocha J, Gozzetti A, Usnarska-Zubkiewicz L, Valls JD, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Szukalski L, Jamroziak K, Hus I, Avivi I, Cohen Y, Mazur P, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Robak P, Gentile M, Kozlowska I, Goldberg SL, Czepiel J, Dlugosz-Danecka M, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Vesole DH, Bittrich M, Kort?m KM, Rosi?ol L, Gonz?lez-Calle V, Mateos MV. Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients. Leuk Lymphoma. 2020 08; 61(8):1885-1893. PMID: 32306794.
      Citations: 1     Fields:    Translation:Humans
    69. Beltran BE, Castro D, Paredes S, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 04; 95(4):435-445. PMID: 32072672.
      Citations: 10     Fields:    Translation:HumansCells
    70. Goldman-Mazur S, Jurczyszyn A, Castillo JJ, Waszczuk-Gajda A, Grzasko N, Radocha J, Gozzetti A, Usnarska-Zubkiewicz L, Davila Valls J, Jayabalan DS, Niesvizky R, Kelman J, Coriu D, Szukalski L, Mateos MV, Jamroziak K, Hus I, Avivi I, Cohen Y, Suska A, Chappell A, Madduri D, Chhabra S, Kleman A, Hari P, Delforge M, Gentile M, Goldberg SL, Czepiel J, Silbermann R, Olszewski AJ, Barth P, Mikala G, Chim CS, Dlugosz-Danecka M, Grosicki S, Vesole DH, Bittrich M, Kort?m KM, Rosi?ol L, Gonz?lez-Calle V, Robak P, Kozlowska I. A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma. Am J Hematol. 2020 05; 95(5):503-509. PMID: 32072687.
      Citations: 4     Fields:    Translation:Humans
    71. Chan GG, Xu L, Tsakmaklis N, Kofides A, Demos MG, Chen J, Liu X, Munshi M, Yang G, Castillo JJ, Wiestner A, Treon SP, Hunter ZR, Jim?nez C, Garc?a-Sanz R. Genomic evolution of ibrutinib-resistant clones in Waldenstr?m macroglobulinaemia. Br J Haematol. 2020 06; 189(6):1165-1170. PMID: 32103491; PMCID: PMC7299825.
      Citations: 14     Fields:    Translation:HumansCellsCTClinical Trials
    72. Sklavenitis-Pistofidis R, Bustoros M, Sacco A, Roccaro A, Branagan AR, Ghobrial IM, Treon SP, Xu L, Guerrera ML, Jimenez C, Hunter ZR, Liu X, Demos M, Gustine J, Chan G, Munshi M, Tsakmaklis N, Chen JG, Kofides A, Keezer A, Meid K, Patterson CJ, Yang G, Castillo JJ. Genomic Landscape of Waldenstr?m Macroglobulinemia and Its Impact on Treatment Strategies. J Clin Oncol. 2020 04 10; 38(11):1198-1208. PMID: 32083995; PMCID: PMC7351339.
      Citations: 28     Fields:    Translation:Humans
    73. Munshi M, Liu X, Chen JG, Xu L, Tsakmaklis N, Demos MG, Kofides A, Guerrera ML, Jimenez C, Chan GG, Hunter ZR, Palomba ML, Argyropoulos KV, Meid K, Keezer A, Gustine J, Dubeau T, Castillo JJ, Patterson CJ, Wang J, Buhrlage SJ, Gray NS, Treon SP, Yang G. SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas. Blood Cancer J. 2020 01 31; 10(1):12. PMID: 32005797; PMCID: PMC6994488.
      Citations: 13     Fields:    Translation:HumansCells
    74. Castillo JJ, Itchaki G, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenstr?m macroglobulinemia. Leuk Lymphoma. 2020 06; 61(6):1388-1394. PMID: 31992103.
      Citations: 2     Fields:    Translation:Humans
    75. Castillo JJ, Gustine JN, Meid K, Flynn CA, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. CXCR4 mutational status does not impact outcomes in patients with Waldenstr?m macroglobulinemia treated with proteasome inhibitors. Am J Hematol. 2020 04; 95(4):E95-E98. PMID: 31943341.
      Citations: 3     Fields:    Translation:Humans
    76. Castillo JJ, Gustine JN, Keezer A, Meid K, Flynn CA, Dubeau TE, Chan G, Chen J, Demos MG, Guerrera ML, Jimenez C, Kofides A, Liu X, Munshi M, Tsakmaklis N, Patterson CJ, Xu L, Yang G, Hunter ZR, Treon SP. Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia. Am J Hematol. 2020 04; 95(4):372-378. PMID: 31868242.
      Citations:    Fields:    Translation:Humans
    77. Olszewski AJ, Butera JN, Reagan JL, Castillo JJ. Outcomes of bendamustine- or cyclophosphamide-based first-line chemotherapy in older patients with indolent B-cell lymphoma. Am J Hematol. 2020 04; 95(4):354-361. PMID: 31849108.
      Citations: 8     Fields:    Translation:Humans
    78. Castillo JJ, Treon SP. What is new in the treatment of Waldenstrom macroglobulinemia? Leukemia. 2019 11; 33(11):2555-2562. PMID: 31591468.
      Citations: 6     Fields:    Translation:Humans
    79. Castillo JJ, Treon SP. How we manage Bing-Neel syndrome. Br J Haematol. 2019 11; 187(3):277-285. PMID: 31430829.
      Citations: 6     Fields:    Translation:Humans
    80. Bustoros M, Sklavenitis-Pistofidis R, Castillo JJ, Treon SP, Ghobrial IM. Reply to F.D. Leonard. J Clin Oncol. 2019 10 10; 37(29):2701-2702. PMID: 31424980.
      Citations:    Fields:    Translation:Humans
    81. Avivi I, Cohen YC, Suska A, Shragai T, Mikala G, Glickman S, Jayabalan DS, Niesvizky R, Gozzetti A, Wisniewska-Piaty K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Hus I, Guzicka R, Radocha J, Milunovic V, Gentile M, Castillo JJ, Jurczyszyn A, Garderet L, Seny GM, Davila J. Hematogenous extramedullary relapse in multiple myeloma - a multicenter retrospective study in 127 patients. Am J Hematol. 2019 10; 94(10):1132-1140. PMID: 31334859.
      Citations: 9     Fields:    Translation:HumansCells
    82. Castillo JJ. HOLA! from Latin America to the myeloma world. Br J Haematol. 2020 02; 188(3):349-350. PMID: 31378927.
      Citations: 1     Fields:    Translation:Humans
    83. Moreno DF, Arbelaez MI, Castillo JJ, Hunter ZR, Treon SP. CXCR4 mutations affect presentation and outcomes in patients with Waldenstr?m macroglobulinemia: A systematic review. Expert Rev Hematol. 2019 10; 12(10):873-881. PMID: 31343930.
      Citations: 7     Fields:    Translation:Humans
    84. Castillo JJ, Xu L, Gustine JN, Keezer A, Meid K, Dubeau TE, Liu X, Demos MG, Kofides A, Tsakmaklis N, Chen JG, Munshi M, Guerrera ML, Chan GG, Patterson CJ, Yang G, Hunter ZR, Treon SP. CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr?m macroglobulinaemia treated with ibrutinib. Br J Haematol. 2019 11; 187(3):356-363. PMID: 31267520.
      Citations: 25     Fields:    Translation:Humans
    85. Paredes S, Castro D, Cotrina E, Sotomayor EM, Castillo JJ, Beltran BE. High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy. Clin Lymphoma Myeloma Leuk. 2019 09; 19(9):e551-e557. PMID: 31320254.
      Citations: 2     Fields:    Translation:Humans
    86. Castillo JJ, Ju?rez-Salcedo LM. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma. Hematol Oncol Clin North Am. 2019 08; 33(4):639-656. PMID: 31229160.
      Citations: 4     Fields:    Translation:Humans
    87. Bustoros M, Sklavenitis-Pistofidis R, Kapoor P, Liu CJ, Kastritis E, Zanwar S, Fell G, Abeykoon JP, Hornburg K, Neuse CJ, Marinac CR, Liu D, Soiffer J, Gavriatopoulou M, Boehner C, Cappuccio JM, Dumke H, Reyes K, Soiffer RJ, Kyle RA, Treon SP, Castillo JJ, Dimopoulos MA, Ansell SM, Trippa L, Ghobrial IM. Progression Risk Stratification of Asymptomatic Waldenstr?m Macroglobulinemia. J Clin Oncol. 2019 06 01; 37(16):1403-1411. PMID: 30990729; PMCID: PMC6544461.
      Citations: 14     Fields:    Translation:Humans
    88. Paludo J, Varettoni M, Buske C, Eyre TA, Chavez JC, Shain KH, Issa S, Palomba ML, Pasvolsky O, Simpson D, Talaulikar D, Tam CS, Tedeschi A, Ansell SM, Nayak L, Castillo JJ, Itchaki G, Treon SP. Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study. Blood. 2019 01 24; 133(4):299-305. PMID: 30523119.
      Citations: 12     Fields:    Translation:Humans
    89. Cheng MP, Kusztos AE, Dryden-Peterson SL, Woolley AE, Hammond SP, Baden LR, Treon SP, Castillo JJ, Issa NC, Gustine JN, Dubeau TE. Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenstr?m macroglobulinaemia on ibrutinib. Br J Haematol. 2019 05; 185(4):788-790. PMID: 30460682.
      Citations: 4     Fields:    Translation:HumansAnimals
    90. Barth P, Castillo JJ, Olszewski AJ. Outcomes of secondary solid tumor malignancies among patients with myeloma: A population-based study. Cancer. 2019 02 15; 125(4):550-558. PMID: 30452087.
      Citations: 1     Fields:    Translation:Humans
    91. Olszewski AJ, Castillo JJ. Ibrutinib and Rituximab in Waldenstr?m's Macroglobulinemia. N Engl J Med. 2018 11 15; 379(20):1973-4. PMID: 30439672.
      Citations: 1     Fields:    Translation:Humans
    92. Babwah A, Gustine J, Meid K, Dubeau T, Xu L, Yang G, Hunter ZR, Treon SP, Castillo JJ. Long survival in patients with Waldenstr?m macroglobulinaemia diagnosed at a young age. Br J Haematol. 2019 05; 185(4):799-802. PMID: 30407630.
      Citations: 1     Fields:    Translation:Humans
    93. Sklavenitis-Pistofidis R, Capelletti M, Liu CJ, Reidy M, Zavidij O, Huynh D, Henrick P, Savell A, Reyes K, Rivotto B, Bustoros M, Perilla-Glen A, Trippa L, Castillo JJ, Treon SP, Ghobrial IM. Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients. Blood. 2018 12 13; 132(24):2608-2612. PMID: 30366921; PMCID: PMC6293872.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    94. Bouyssou JM, Liu CJ, Bustoros M, Sklavenitis-Pistofidis R, Aljawai Y, Manier S, Yosef A, Sacco A, Kokubun K, Tsukamoto S, Perilla Glen A, Huynh D, Castillo JJ, Treon SP, Hermine O, Roccaro AM, Ghobrial IM, Capelletti M, Leblond V. Profiling of circulating exosomal miRNAs in patients with Waldenstr?m Macroglobulinemia. PLoS One. 2018; 13(10):e0204589. PMID: 30286096; PMCID: PMC6171840.
      Citations: 8     Fields:    Translation:HumansCells
    95. Kastritis E, Castillo JJ, Treon SP. Waldenstr?m Macroglobulinemia: Lessons Learned from Basic and Clinical Research. Hematol Oncol Clin North Am. 2018 10; 32(5):xiii-xiv. PMID: 30190026.
      Citations:    Fields:    Translation:Humans
    96. Gustine JN, Tsakmaklis N, Demos MG, Kofides A, Chen JG, Liu X, Munshi M, Guerrera ML, Chan GG, Patterson CJ, Meid K, Dubeau T, Yang G, Hunter ZR, Treon SP, Castillo JJ, Xu L. TP53 mutations are associated with mutated MYD88 and CXCR4, and confer an adverse outcome in Waldenstr?m macroglobulinaemia. Br J Haematol. 2019 01; 184(2):242-245. PMID: 30183082.
      Citations: 8     Fields:    Translation:Humans
    97. Jurczyszyn A, Castillo JJ, Vesole DH, Liu J, Avivi I, Waszczuk-Gajda A, Lech-Maranda E, Gentile M, Mikala G, Guerrero-Garcia T, Suska A, Gertz MA. Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study. Am J Hematol. 2018 09; 93(9):E238-E241. PMID: 29989240.
      Citations:    Fields:    Translation:Humans
    98. Treon SP, Gustine J, Meid K, Yang G, Xu L, Liu X, Demos M, Kofides A, Tsakmaklis N, Chen JG, Munshi M, Chan G, Dubeau T, Raje N, Yee A, O'Donnell E, Hunter ZR, Castillo JJ. Ibrutinib Monotherapy in Symptomatic, Treatment-Na?ve Patients With Waldenstr?m Macroglobulinemia. J Clin Oncol. 2018 09 20; 36(27):2755-2761. PMID: 30044692.
      Citations: 53     Fields:    Translation:HumansCTClinical Trials
    99. Treon SP, Xu L, Liu X, Hunter ZR, Yang G, Castillo JJ. Genomic Landscape of Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2018 10; 32(5):745-752. PMID: 30190014.
      Citations: 2     Fields:    Translation:HumansCells
    100. Castillo JJ, Treon SP. Initial Evaluation of the Patient with Waldenstr?m Macroglobulinemia. Hematol Oncol Clin North Am. 2018 10; 32(5):811-820. PMID: 30190019.
      Citations: 4     Fields:    Translation:Humans
    101. Jurczyszyn A, Davila J, Jayabalan DS, Vij R, Fiala M, Milunovic V, Chim CS, Wisniewska-Piaty K, Waszczuk-Gajda A, Crusoe E, Hajek R, Robak P, Razny M, Zawirska D, Nahi H, Liu J, Castillo JJ, Vesole DH, Kort?m KM, Bittrich M. Multiple myeloma in patients up to 30?years of age: a multicenter retrospective study of 52 cases. Leuk Lymphoma. 2019 02; 60(2):471-476. PMID: 30033832.
      Citations: 5     Fields:    Translation:Humans
    102. Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grzasko N, Milunovic V, Hus I, Madry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Debski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charlinski G, Gyula Szabo A, Hajek R, Delforge M, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH, Kopacz A. Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients. Leuk Lymphoma. 2019 01; 60(1):118-123. PMID: 29965787.
      Citations: 7     Fields:    Translation:Humans
    103. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management. Am J Hematol. 2018 07; 93(7):953-962. PMID: 29984868.
      Citations: 26     Fields:    Translation:HumansCells
    104. Treon SP, Castillo JJ. The real world of Waldenstr?m's macroglobulinaemia. Lancet Haematol. 2018 07; 5(7):e275-e276. PMID: 29958567.
      Citations: 2     Fields:    Translation:Humans
    105. Castillo JJ. Viral lymphomagenesis: beyond the usual suspects. Br J Haematol. 2018 09; 182(5):617-618. PMID: 29808932.
      Citations:    Fields:    Translation:HumansCells
    106. Castillo JJ, Gustine JN, Meid K, Dubeau TE, Xu L, Yang G, Hunter ZR, Advani R, Palomba L, Treon SP. Impact of ibrutinib dose intensity on patient outcomes in previously treated Waldenstr?m macroglobulinemia. Haematologica. 2018 10; 103(10):e466-e468. PMID: 29773590; PMCID: PMC6165799.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    107. Castillo JJ, Dubeau T, Kofides A, Demos MG, Tsakmaklis N, Xu L, Hunter ZR, Treon SP. Spotting the elusive Siberian tiger: Complete response to ibrutinib in a patient with Waldenstr?m Macroglobulinemia. Am J Hematol. 2018 May 14. PMID: 29756293.
      Citations: 1     Fields:    
    108. Castillo JJ, Gustine JN, Treon SP. Fitting mSMART Into the Current Clinical Management of Waldenstr?m Macroglobulinemia. JAMA Oncol. 2018 05 01; 4(5):744-745. PMID: 29392274.
      Citations:    Fields:    Translation:Humans
    109. Singh A, Geller HI, Alexander KM, Padera RF, Mitchell RN, Dorbala S, Castillo JJ, Falk RH. True, true unrelated? Coexistence of Waldenstr?m macroglobulinemia and cardiac transthyretin amyloidosis. Haematologica. 2018 08; 103(8):e374-e376. PMID: 29674499; PMCID: PMC6068030.
      Citations: 1     Fields:    Translation:Humans
    110. Castillo JJ, Gustine JN, Meid K, Dubeau T, Severns P, Xu L, Yang G, Hunter ZR, Treon SP. Low levels of von Willebrand markers associate with high serum IgM levels and improve with response to therapy, in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2019 03; 184(6):1011-1014. PMID: 29532913.
      Citations: 6     Fields:    Translation:Humans
    111. Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, Cwynarski K, Dierickx D, Tousseyn T, Lansigan F, Linnik Y, Mogollon R, Olszewski AJ, Reagan JL, Fedele P, Gilbertson M, Grigoriadis G, Bibas M, Navarro JT. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. Br J Haematol. 2019 02; 184(4):679-682. PMID: 29527667.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    112. Beltran BE, Castro D, De La Cruz-Vargas JA, Cotrina E, Gallo A, Sotomayor EM, Castillo JJ. The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma. Br J Haematol. 2019 02; 184(4):650-653. PMID: 29479670.
      Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
    113. Castillo JJ, Gustine JN, Meid K, Dubeau TE, Severns P, Xu L, Yang G, Hunter ZR, Treon SP. Response and survival for primary therapy combination regimens and maintenance rituximab in Waldenstr?m macroglobulinaemia. Br J Haematol. 2018 04; 181(1):77-85. PMID: 29468652.
      Citations: 11     Fields:    Translation:Humans
    114. Castillo JJ, Gustine JN, Meid K, Dubeau T, Severns P, Treon SP. Ibrutinib withdrawal symptoms in patients with Waldenstr?m macroglobulinemia. Haematologica. 2018 07; 103(7):e307-e310. PMID: 29472352; PMCID: PMC6029546.
      Citations: 13     Fields:    Translation:Humans
    115. Paredes S, Cotrina E, Sotomayor EM, Castillo JJ, Beltr?n BE. The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma. Leuk Res. 2018 04; 67:82-85. PMID: 29477024.
      Citations: 2     Fields:    Translation:HumansCells
    116. Gustine JN, Meid K, Dubeau T, Severns P, Hunter ZR, Guang Y, Xu L, Treon SP, Castillo JJ. Ibrutinib discontinuation in Waldenstr?m macroglobulinemia: Etiologies, outcomes, and IgM rebound. Am J Hematol. 2018 08; 93(4):511-517. PMID: 29280186.
      Citations: 16     Fields:    Translation:Humans
    117. Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grzasko N, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charlinski G, Hajek R, Delforge M, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopinska-Posluszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ, Robak P, Szabo AG, Kopacz A. Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients. Br J Haematol. 2018 03; 180(6):831-839. PMID: 29315478.
      Citations: 17     Fields:    Translation:HumansCTClinical Trials
    118. Castillo JJ, Gustine JN, Meid K, Xu L, Hunter ZR, Treon SP. Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia. Am J Hematol. 2018 03; 93(3):E69-E71. PMID: 29218718.
      Citations:    Fields:    Translation:Humans
    119. Castillo JJ, Treon SP. Toward personalized treatment in Waldenstr?m macroglobulinemia. Hematology Am Soc Hematol Educ Program. 2017 12 08; 2017(1):365-370. PMID: 29222280; PMCID: PMC6142554.
      Citations: 1     Fields:    Translation:Humans
    120. Treon SP, Castillo JJ. What should be the goal of therapy for Waldenstr?m macroglobulinemia patients? Complete response should be the goal of therapy. Blood Adv. 2017 Nov 28; 1(25):2486-2490. PMID: 29296899; PMCID: PMC5729614.
      Citations: 2     Fields:    
    121. Treon SP, Gustine J, Xu L, Manning RJ, Tsakmaklis N, Demos M, Meid K, Guerrera ML, Munshi M, Chan G, Chen J, Kofides A, Patterson CJ, Yang G, Liu X, Severns P, Dubeau T, Hunter ZR, Castillo JJ. MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and?overall survival. Br J Haematol. 2018 02; 180(3):374-380. PMID: 29181840.
      Citations: 25     Fields:    Translation:Humans
    122. Beltran BE, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ, Qui?ones P. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course? Leuk Lymphoma. 2018 07; 59(7):1753-1755. PMID: 29081245.
      Citations: 2     Fields:    Translation:Humans
    123. Olszewski AJ, Reagan JL, Castillo JJ. Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomas. Am J Hematol. 2018 01; 93(1):E1-E3. PMID: 28960532.
      Citations: 7     Fields:    Translation:Humans
    124. Qunaj L, Castillo JJ, Olszewski AJ. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma. 2018 06; 59(6):1375-1383. PMID: 29019447.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    125. Guerrero-Garcia TA, Mogollon RJ, Castillo JJ. Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat disease. Leuk Res. 2017 11; 62:12-16. PMID: 28963907.
      Citations: 16     Fields:    Translation:Humans
    126. Gozzetti A, Vij R, Fiala M, Valls DJ, Madry K, Waszczuk-Gajda A, Grosicki S, Barchnicka A, Crusoe E, Hungria V, Gentile M, Mele G, Ksieniewicz M, Vesole DH, Castillo JJ, Jurczyszyn A, Gdula-Argasinska J, Czepiel J. Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study. Ann Hematol. 2017 Oct; 96(10):1693-1698. PMID: 28766002.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    127. Olszewski AJ, Chen C, Gutman R, Treon SP, Castillo JJ. Comparative outcomes of immunochemotherapy regimens in Waldenstr?m macroglobulinaemia. Br J Haematol. 2017 10; 179(1):106-115. PMID: 28677830.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    128. Castillo JJ, Hunter ZR, Yang G, Treon SP. Novel approaches to targeting MYD88 in Waldenstr?m macroglobulinemia. Expert Rev Hematol. 2017 08; 10(8):739-744. PMID: 28617062.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    129. Beltran BE, Morales D, Malaga JM, Chavez JC, Sotomayor EM, Castillo JJ, Qui?ones P. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma. Hematol Oncol. 2018 Feb; 36(1):93-97. PMID: 28639256.
      Citations: 8     Fields:    Translation:Humans
    130. Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA. IgM myeloma: A multicenter retrospective study of 134 patients. Am J Hematol. 2017 Aug; 92(8):746-751. PMID: 28383205.
      Citations: 12     Fields:    Translation:HumansCells
    131. Gustine JN, Meid K, Dubeau T, Hunter ZR, Xu L, Yang G, Ghobrial IM, Treon SP, Castillo JJ. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2017 06; 177(5):717-725. PMID: 28485115.
      Citations: 12     Fields:    Translation:Humans
    132. Hunter ZR, Yang G, Xu L, Liu X, Castillo JJ, Treon SP. Genomics, Signaling, and Treatment of Waldenstr?m Macroglobulinemia. J Clin Oncol. 2017 Mar 20; 35(9):994-1001. PMID: 28294689.
      Citations: 29     Fields:    Translation:HumansCells
    133. Dimopoulos MA, Trotman J, Tedeschi A, Matous JV, Macdonald D, Tam C, Ma S, Heffner LT, Shustik C, Cornell RF, Castillo JJ, Granell M, Kyrtsonis MC, Symeonidis A, Kastritis E, Singh P, Li J, Graef T, Bilotti E, Treon S, Buske C, Tournilhac O, Oriol A, Garc?a-Sanz R, de Larrea CF, Leblond V, iNNOVATE Study Group and the European Consortium for Waldenstr?m's Macroglobulinemia. Ibrutinib for patients with rituximab-refractory Waldenstr?m's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. Lancet Oncol. 2017 Feb; 18(2):241-250. PMID: 27956157.
      Citations: 72     Fields:    Translation:HumansCTClinical Trials
    134. Treon SP, Meid K, Tripsas C, Heffner LT, Eradat H, Badros AZ, Xu L, Hunter ZR, Yang G, Patterson CJ, Gustine J, Castillo JJ, Matous J, Ghobrial IM. Prospective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214). Clin Cancer Res. 2017 May 15; 23(10):2400-2404. PMID: 27836860.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    135. Gustine JN, Meid K, Hunter ZR, Xu L, Treon SP, Castillo JJ. MYD88 mutations can be used to identify malignant pleural effusions in Waldenstr?m macroglobulinaemia. Br J Haematol. 2018 02; 180(4):578-581. PMID: 27748515.
      Citations: 7     Fields:    Translation:Humans
    136. Castillo JJ. Plasma Cell Disorders. Prim Care. 2016 Dec; 43(4):677-691. PMID: 27866585.
      Citations: 5     Fields:    Translation:HumansCells
    137. Argyropoulos K, Palomba ML, Castillo JJ, Hunter ZR, Yang G, Treon SP. Future therapeutic options for patients with Waldenstr?m macroglobulinemia. Best Pract Res Clin Haematol. 2016 06; 29(2):206-215. PMID: 27825467.
      Citations: 2     Fields:    Translation:Humans
    138. Castillo JJ. Risk factors for progression from smoldering into active myeloma: additional insights from a population-based study. Eur J Haematol. 2016 Sep; 97(3):217-8. PMID: 26918423.
      Citations:    Fields:    Translation:HumansPHPublic Health
    139. Olszewski AJ, Mantripragada KC, Castillo JJ. Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma. J Natl Compr Canc Netw. 2016 09; 14(9):1121-9. PMID: 27587624.
      Citations: 5     Fields:    Translation:Humans
    140. Castillo JJ, Gustine JN, Meid K, Dubeau T, Yang G, Xu L, Hunter ZR, Treon SP. Idelalisib in Waldenstr?m macroglobulinemia: high incidence of hepatotoxicity. Leuk Lymphoma. 2017 04; 58(4):1002-1004. PMID: 27562445.
      Citations: 11     Fields:    Translation:Humans
    141. Gertz MA, Castillo JJ. Secondary malignancies in patients with multiple myeloma, Waldenstr?m macroglobulinemia and monoclonal gammopathy of undetermined significance. Leuk Lymphoma. 2017 04; 58(4):773-780. PMID: 27546465.
      Citations: 10     Fields:    Translation:Humans
    142. Olszewski AJ, Treon SP, Castillo JJ. Evolution of Management and Outcomes in Waldenstr?m Macroglobulinemia: A Population-Based Analysis. Oncologist. 2016 Nov; 21(11):1377-1386. PMID: 27473042; PMCID: PMC5189618.
      Citations: 15     Fields:    
    143. Levin SN, de Gusmao CM, Etherton MR, Will Rondeau M, Meredith DM, Folkerth RD, Klein JP, Nadeem O, Castillo JJ. "All the soarings of my mind begin in my blood:" central nervous system complication of Waldenstr?m macroglobulinemia. Am J Hematol. 2016 Oct; 91(10):1057-60. PMID: 27414991.
      Citations:    Fields:    Translation:Humans
    144. Rennke HG, Minnema MC, Kersten MJ, Vos JM, Gustine J, Hunter Z, Manning RJ, Dubeau TE, Meid K, Treon SP, Castillo JJ. Renal disease related to Waldenstr?m macroglobulinaemia: incidence, pathology and clinical outcomes. Br J Haematol. 2016 Nov; 175(4):623-630. PMID: 27468978.
      Citations: 23     Fields:    Translation:Humans
    145. Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr?m macroglobulinemia. Am J Hematol. 2016 10; 91(10):1032-5. PMID: 27415417.
      Citations: 16     Fields:    Translation:Humans
    146. Mason C, Savona S, Rini JN, Castillo JJ, Xu L, Hunter ZR, Treon SP, Allen SL. Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. Br J Haematol. 2017 10; 179(2):339-341. PMID: 27409073.
      Citations: 21     Fields:    Translation:Humans
    147. Garcia-Sanz R, Hatjiharissi E, Kyle RA, Leleu X, McMaster M, Merlini G, Minnema MC, Morra E, Owen RG, Stone MJ, Tam C, Varettoni M, Dimopoulos MA, Kastritis E, Castillo JJ, Poulain S, Treon SP. Recommendations for the diagnosis and initial evaluation of patients with Waldenstr?m Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenstr?m Macroglobulinaemia. Br J Haematol. 2016 10; 175(1):77-86. PMID: 27378193; PMCID: PMC5154335.
      Citations: 16     Fields:    Translation:Humans
    148. Olszewski AJ, Fallah J, Castillo JJ. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base. Cancer. 2016 09 01; 122(17):2689-97. PMID: 27337679.
      Citations: 17     Fields:    Translation:Humans
    149. Anderson KC, Munshi NM, Hunter ZR, Xu L, Yang G, Tsakmaklis N, Vos JM, Liu X, Chen J, Manning RJ, Chen JG, Brodsky P, Patterson CJ, Gustine J, Dubeau T, Castillo JJ, Treon SP. Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenstr?m macroglobulinemia. Blood. 2016 08 11; 128(6):827-38. PMID: 27301862; PMCID: PMC4982454.
      Citations: 38     Fields:    Translation:HumansCells
    150. Palomba ML, Advani R, Castillo JJ, Treon SP. Ibrutinib in Waldenstr?m macroglobulinemia: latest evidence and clinical experience. Ther Adv Hematol. 2016 Aug; 7(4):179-86. PMID: 27493708; PMCID: PMC4959643.
      Citations: 11     
    151. Yang G, Buhrlage SJ, Tan L, Liu X, Chen J, Xu L, Tsakmaklis N, Chen JG, Patterson CJ, Brown JR, Castillo JJ, Zhang W, Zhang X, Liu S, Cohen P, Hunter ZR, Gray N, Treon SP. HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib. Blood. 2016 06 23; 127(25):3237-52. PMID: 27143257.
      Citations: 46     Fields:    Translation:HumansCells
    152. Castillo JJ, Marini C, Baldaia H, Trigo F. Transformation of a previously diagnosed diffuse large B-cell lymphoma to plasmablastic lymphoma. Am J Hematol. 2016 Aug; 91(8):E324. PMID: 27012155.
      Citations: 2     Fields:    Translation:HumansCells
    153. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol. 2016 May; 91(5):529-37. PMID: 27093913.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    154. Gustine JN, Meid K, Dubeau TE, Treon SP, Castillo JJ. Atrial fibrillation associated with ibrutinib in Waldenstr?m macroglobulinemia. Am J Hematol. 2016 06; 91(6):E312-3. PMID: 26994323.
      Citations: 12     Fields:    Translation:HumansCTClinical Trials
    155. Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Crusoe E, Silva Dias AL, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski J, Corso A, Cocito F, Vekemans MC, Atilla E, Beksac M, Leleu X, Davila J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H, Zweegman S, Castillo JJ. Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice. Am J Hematol. 2016 06; 91(6):575-80. PMID: 26955792; PMCID: PMC5502095.
      Citations: 33     Fields:    Translation:Humans
    156. Liu X, Hunter ZR, Xu L, Chen J, Chen JG, Tsakmaklis N, Patterson CJ, Castillo JJ, Buhrlage S, Gray N, Treon SP, Yang G. Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia. Br J Haematol. 2017 06; 177(5):808-813. PMID: 27073043.
      Citations: 7     Fields:    Translation:HumansCells
    157. Castillo JJ, Ghobrial IM, Treon SP. Response to ibrutinib in a patient with IgG lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation. Leuk Lymphoma. 2016 11; 57(11):2699-701. PMID: 26980069.
      Citations: 3     Fields:    Translation:Humans
    158. Olszewski AJ, Castillo JJ. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy. AIDS. 2016 Mar 13; 30(5):787-96. PMID: 26730566.
      Citations: 8     Fields:    Translation:Humans
    159. Gustine J, Meid K, Xu L, Hunter ZR, Castillo JJ, Treon SP. To select or not to select? The role of B-cell selection in determining the MYD88 mutation status in Waldenstr?m Macroglobulinaemia. Br J Haematol. 2017 03; 176(5):822-824. PMID: 26936399.
      Citations: 11     Fields:    Translation:HumansCells
    160. Roccaro AM, Sacco A, Shi J, Chiarini M, Perilla-Glen A, Manier S, Glavey S, Aljawai Y, Mishima Y, Kawano Y, Moschetta M, Correll M, Improgo MR, Brown JR, Imberti L, Rossi G, Castillo JJ, Treon SP, Freedman ML, Van Allen EM, Hide W, Hiller E, Rainville I, Ghobrial IM. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenstr?m macroglobulinemia. Blood. 2016 05 26; 127(21):2598-606. PMID: 26903547.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    161. Olszewski AJ, Falah J, Castillo JJ. Survival Claims From Observational Data on Cancer Therapy. J Clin Oncol. 2016 Apr 20; 34(12):1425-7. PMID: 26884574.
      Citations: 2     Fields:    Translation:Humans
    162. Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma. 2016 09; 57(9):2071-6. PMID: 26726867.
      Citations: 15     Fields:    Translation:Humans
    163. Treon SP, Davids MS, Castillo JJ. Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders. Cancer J. 2016 Jan-Feb; 22(1):34-9. PMID: 26841015.
      Citations: 9     Fields:    Translation:HumansCells
    164. Castillo JJ, D'Sa S, Lunn MP, Minnema MC, Tedeschi A, Lansigan F, Palomba ML, Varettoni M, Garcia-Sanz R, Nayak L, Lee EQ, Rinne ML, Norden AD, Ghobrial IM, Treon SP. Central nervous system involvement by Waldenstr?m macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study. Br J Haematol. 2016 Mar; 172(5):709-15. PMID: 26686858; PMCID: PMC5480405.
      Citations: 20     Fields:    Translation:Humans
    165. Tai YT, Zehnder JL, Brown JR, Carrasco RD, Advani R, Sabile JM, Argyropoulos K, Lia Palomba M, Morra E, Trojani A, Greco A, Tedeschi A, Varettoni M, Arcaini L, Munshi NM, Anderson KC, Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, Liu X, Kanan S, Castillo JJ, Treon SP. Clonal architecture of CXCR4 WHIM-like mutations in Waldenstr?m Macroglobulinaemia. Br J Haematol. 2016 Mar; 172(5):735-44. PMID: 26659815; PMCID: PMC5409813.
      Citations: 51     Fields:    Translation:Humans
    166. Castillo JJ, Mulkey F, Geyer S, Kolitz JE, Blum W, Powell BL, George SL, Larson RA, Stone RM. Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials. Am J Hematol. 2016 Feb; 91(2):199-204. PMID: 26526191; PMCID: PMC4724329.
      Citations: 17     Fields:    Translation:Humans
    167. Castillo JJ, Kanan S, Meid K, Manning R, Hunter ZR, Treon SP. Rituximab intolerance in patients with Waldenstr?m macroglobulinaemia. Br J Haematol. 2016 08; 174(4):645-8. PMID: 26523929.
      Citations: 14     Fields:    Translation:Humans
    168. Beltran BE, Aguilar C, Morales D, Chavez JC, Sotomayor EM, Castillo JJ, Qui?ones P. The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2016; 57(1):58-62. PMID: 25926063.
      Citations: 13     Fields:    Translation:HumansCells
    169. Olszewski AJ, Winer ES, Castillo JJ. Validation of clinical prognostic indices for diffuse large B-cell lymphoma in the National Cancer Data Base. Cancer Causes Control. 2015 Aug; 26(8):1163-72. PMID: 26054914.
      Citations: 10     Fields:    Translation:Humans
    170. Olszewski AJ, Castillo JJ, Kanan S, Meid K, Hunter ZR, Treon SP. Survival outcomes of secondary cancers in patients with Waldenstr?m macroglobulinemia: An analysis of the SEER database. Am J Hematol. 2015 Aug; 90(8):696-701. PMID: 25963924.
      Citations: 4     Fields:    Translation:Humans
    171. Leblebjian H, Noonan K, Paba-Prada C, Treon SP, Castillo JJ, Ghobrial IM. Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia. Am J Hematol. 2015 Jun; 90(6):E122-3. PMID: 25703132.
      Citations: 3     Fields:    Translation:Humans
    172. Reagan JL, Sullivan MR, Winer ES, Lansigan F, Cardin MS, Castillo JJ. Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study. Leuk Res. 2015 Aug; 39(8):812-7. PMID: 26045177.
      Citations: 1     Fields:    Translation:Humans
    173. Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ, Rodig S, Zehnder JL, Aster JC, Harris NL, Kanan S, Ghobrial I, Castillo JJ, Laubach JP, Hunter ZR, Salman Z, Li J, Cheng M, Clow F, Graef T, Palomba ML, Advani RH, Treon SP. Ibrutinib in previously treated Waldenstr?m's macroglobulinemia. N Engl J Med. 2015 Apr 09; 372(15):1430-40. PMID: 25853747.
      Citations: 280     Fields:    Translation:HumansCTClinical Trials
    174. Garg M, Lee BE, McGarry K, Mangray S, Castillo JJ. CD20-negative diffuse large B-cell lymphoma presenting with lactic acidosis. Am J Hematol. 2015 Mar; 90(3):E49-50. PMID: 25417998.
      Citations: 5     Fields:    Translation:HumansCells
    175. Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options. Expert Rev Hematol. 2015 Jun; 8(3):343-54. PMID: 25641215.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    176. Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015 Apr 09; 125(15):2323-30. PMID: 25636338.
      Citations: 125     Fields:    Translation:HumansAnimalsCells
    177. Castillo JJ, Reagan JL, Sikov WM, Winer ES. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma. Br J Haematol. 2015 May; 169(3):352-5. PMID: 25612847.
      Citations: 32     Fields:    Translation:Humans
    178. Cao Y, Yang G, Hunter ZR, Liu X, Xu L, Chen J, Tsakmaklis N, Hatjiharissi E, Kanan S, Davids MS, Castillo JJ, Treon SP. The BCL2 antagonist ABT-199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4 Wild-type and CXCR4 WHIM mutated Waldenstrom macroglobulinaemia cells. Br J Haematol. 2015 Jul; 170(1):134-8. PMID: 25582069.
      Citations: 34     Fields:    Translation:Humans
    179. Olszewski AJ, Shrestha R, Castillo JJ. Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base. J Clin Oncol. 2015 Feb 20; 33(6):625-33. PMID: 25584010.
      Citations: 27     Fields:    Translation:Humans
    180. Castillo JJ, Ghobrial IM, Treon SP. Biology, prognosis, and therapy of Waldenstr?m Macroglobulinemia. Cancer Treat Res. 2015; 165:177-95. PMID: 25655610.
      Citations: 6     Fields:    Translation:Humans
    181. Jurczyszyn A, Czepiel J, Gdula-Argasinska J, Pasko P, Czapkiewicz A, Librowski T, Perucki W, Butrym A, Castillo JJ, Skotnicki AB. Plasma fatty acid profile in multiple myeloma patients. Leuk Res. 2015 Apr; 39(4):400-5. PMID: 25666255.
      Citations: 10     Fields:    Translation:Humans
    182. Olszewski AJ, Kanan S, Meid K, Hunter ZR, Treon SP, Castillo JJ. Overall survival and competing risks of death in patients with?Waldenstr?m macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database. Br J Haematol. 2015 Apr; 169(1):81-9. PMID: 25521528.
      Citations: 28     Fields:    Translation:Humans
    183. Banwait R, Aljawai Y, Cappuccio J, McDiarmid S, Morgan EA, Leblebjian H, Roccaro AM, Laubach J, Castillo JJ, Paba-Prada C, Treon S, Redd R, Weller E, Ghobrial IM. Extramedullary Waldenstr?m macroglobulinemia. Am J Hematol. 2015 Feb; 90(2):100-4. PMID: 25349134.
      Citations: 14     Fields:    Translation:HumansCells
    184. Cao Y, Hunter ZR, Liu X, Xu L, Yang G, Chen J, Tsakmaklis N, Kanan S, Castillo JJ, Treon SP. CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed survival signalling in Waldenstr?m macroglobulinaemia cells. Br J Haematol. 2015 Mar; 168(5):701-7. PMID: 25371371.
      Citations: 36     Fields:    Translation:HumansCells
    185. Castillo JJ, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA, Beltr?n BE, Qui?ones P. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement. Am J Dermatopathol. 2014 Nov; 36(11):e189-93. PMID: 25238445.
      Citations:    Fields:    Translation:Humans
    186. Vasquez L, Morales D, Paredes G, Miranda RN, Castillo JJ, Beltr?n BE, Maza I, Mois?s-Alfaro CB, Qui?ones P, S?nchez G, Oscanoa M, Ger?nimo J. Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru. Am J Hematol. 2014 Dec; 89(12):1160-1. PMID: 25196949.
      Citations: 7     Fields:    Translation:Humans
    187. Castillo JJ, Bower M, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM, HIV-Associated Hodgkin Lymphoma in the cART Era Study Group, Br?hlmann J. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study. Cancer. 2015 Feb 01; 121(3):423-31. PMID: 25251326.
      Citations: 9     Fields:    Translation:Humans
    188. Aguilar C, Beltran B, Carbajal T, Vilcapaza J, Yabar A, Segura P, Miranda RN, Castillo JJ, Qui?ones P, Quintanilla-Martinez L. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus? Cardiovasc Pathol. 2015 Jan-Feb; 24(1):60-4. PMID: 25307939.
      Citations: 11     Fields:    Translation:Humans
    189. Petrich AM, Gandhi M, Jovanovic B, Castillo JJ, Rajguru S, Yang DT, Shah KA, Whyman JD, Lansigan F, Hernandez-Ilizaliturri FJ, Lee LX, Barta SK, Melinamani S, Karmali R, Adeimy C, Smith S, Dalal N, Nabhan C, Peace D, Vose J, Evens AM, Shah N, Fenske TS, Zelenetz AD, Landsburg DJ, Howlett C, Mato A, Jaglal M, Chavez JC, Tsai JP, Reddy N, Li S, Handler C, Flowers CR, Cohen JB, Blum KA, Song K, Sun HL, Press O, Cassaday R, Jaso J, Medeiros LJ, Sohani AR, Abramson JS. Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood. 2014 Oct 09; 124(15):2354-61. PMID: 25161267.
      Citations: 131     Fields:    Translation:Humans
    190. Merlini G, Treon SP, Hunter ZR, Castillo JJ. Waldenstr?m macroglobulinemia. Hematol Oncol Clin North Am. 2014 Oct; 28(5):945-70. PMID: 25212891.
      Citations: 5     Fields:    Translation:HumansCells
    191. Apor E, O'Brien J, Stephen M, Castillo JJ. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies. Leuk Res. 2014 Sep; 38(9):1067-71. PMID: 25052307.
      Citations: 6     Fields:    Translation:Humans
    192. Olszewski AJ, Cronin AM, Castillo JJ, Hunter ZR, Treon SP. Survival trends in Waldenstr?m macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database. Blood. 2014 Jun 19; 123(25):3999-4000. PMID: 24948623.
      Citations: 22     Fields:    Translation:Humans
    193. Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1877-84. PMID: 24946718.
      Citations: 28     Fields:    Translation:Humans
    194. Turnbull B, Treon SP, Tripsas CK, Meid K, Kanan S, Sheehy P, Chuma S, Xu L, Cao Y, Yang G, Liu X, Patterson CJ, Warren D, Hunter ZR, Ghobrial IM, Castillo JJ. Carfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenstr?m's macroglobulinemia. Blood. 2014 Jul 24; 124(4):503-10. PMID: 24859363.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    195. Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014 Aug; 89(8):E125-32. PMID: 24753145.
      Citations: 33     Fields:    Translation:Humans
    196. Olszewski AJ, Winer ES, Castillo JJ. Improved survival with rituximab-based chemoimmunotherapy in older patients with extranodal diffuse large B-cell lymphoma. Leuk Res. 2014 Aug; 38(8):866-73. PMID: 24837081.
      Citations: 7     Fields:    Translation:Humans
    197. Reagan JL, Castillo JJ. Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia. Future Oncol. 2014 May; 10(7):1147-55. PMID: 24947256.
      Citations: 2     Fields:    Translation:HumansAnimals
    198. Gavini A, Reagan JL, Winer ES, Castillo JJ. Primary refractory Hodgkin lymphoma: limited options and poor survival--but not always. Am J Hematol. 2014 Aug; 89(8):853-7. PMID: 24382755.
      Citations:    Fields:    Translation:Humans
    199. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol. 2014 Mar; 89(3):310-4. PMID: 24273125.
      Citations: 49     Fields:    Translation:Humans
    200. Castillo JJ, Reagan JL, Bishop KD, Apor E. Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies. Br J Haematol. 2014 May; 165(3):300-15. PMID: 24533596.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    201. Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O'Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, de Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014 Jan 10; 32(2):114-20. PMID: 24323027; PMCID: PMC4062709.
      Citations: 96     Fields:    Translation:Humans
    202. Castillo JJ, Ingham RR, Reagan JL, Furman M, Dalia S, Mitri J. Obesity is associated with increased relative risk of diffuse large B-cell lymphoma: a meta-analysis of observational studies. Clin Lymphoma Myeloma Leuk. 2014 Apr; 14(2):122-30. PMID: 24360912.
      Citations: 9     Fields:    Translation:Humans
    203. Castillo JJ, Winer ES, Olszewski AJ. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database. Cancer. 2013 Oct 15; 119(20):3672-9. PMID: 23913575.
      Citations: 19     Fields:    Translation:Humans
    204. Dalia S, Chavez J, Castillo JJ, Sokol L. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Leuk Res. 2013 Sep; 37(9):1107-15. PMID: 23809055.
      Citations: 34     Fields:    Translation:HumansCells
    205. Beltran BE, Morales D, Alva JC, Miranda RN, Lu G, Shah BD, Sotomayor EM, Castillo JJ, Qui?ones P. Follicular lymphoma with leukemic phase at diagnosis: a series of seven cases and review of the literature. Leuk Res. 2013 Sep; 37(9):1116-9. PMID: 23790442; PMCID: PMC4038155.
      Citations: 7     Fields:    Translation:Humans
    206. Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Cellular immunotherapy for refractory hematological malignancies. J Transl Med. 2013 Jun 19; 11:150. PMID: 23782682; PMCID: PMC3689050.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    207. Kuritzky B, Morales D, Lu G, Goswami M, Miranda RN, Castillo JJ, Beltr?n BE, Qui?ones P, Alva JC. Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature. Leuk Lymphoma. 2013 Oct; 54(10):2306-9. PMID: 23363270.
      Citations: 3     Fields:    Translation:HumansCells
    208. Castillo JJ, Sinclair N, Song MK, Ilic I, Leppa S, Nurmi H, Seki R, Uccella S, Li JM, Treaba DO, Stachurski D, Butera JN, Beltr?n BE. Similar outcomes in Asian and Western patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2013 Apr; 37(4):386-91. PMID: 23352640.
      Citations: 4     Fields:    Translation:Humans
    209. Nakhla PS, Butera JN, Treaba DO, Castillo JJ, Quesenberry PJ. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype. Leuk Lymphoma. 2013 Aug; 54(8):1647-51. PMID: 23185961.
      Citations: 4     Fields:    Translation:HumansCells
    210. Castillo JJ, Beltran BE. Not all aggressive adult T-cell leukemia/lymphoma subtypes are created equal. J Clin Oncol. 2012 Oct 01; 30(28):3560; author reply 3561. PMID: 22927519.
      Citations:    Fields:    Translation:Humans
    211. Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013 Feb 01; 119(3):629-38. PMID: 22893605.
      Citations: 56     Fields:    Translation:Humans
    212. Treaba DO, Khedr S, Mangray S, Jackson C, Castillo JJ, Winer ES. Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature. Case Rep Hematol. 2012; 2012:875039. PMID: 22953080; PMCID: PMC3420541.
      Citations:    
    213. Castillo JJ, Shum H, Lahijani M, Winer ES, Butera JN. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved. Leuk Lymphoma. 2012 Dec; 53(12):2378-82. PMID: 22591071.
      Citations: 19     Fields:    Translation:HumansCells
    214. Castillo JJ, Vincent M, Justice E. Diagnosis and management of hyponatremia in cancer patients. Oncologist. 2012; 17(6):756-65. PMID: 22618570; PMCID: PMC3380874.
      Citations: 81     Fields:    Translation:Humans
    215. Castillo JJ, Dhami PK, Curry S, Brennan K. No association between cigarette smoking and incidence of plasma cell myeloma: a meta-analysis of 17 observational studies. Am J Hematol. 2012 Jul; 87(7):729-31. PMID: 22566293.
      Citations: 6     Fields:    Translation:Humans
    216. Castillo JJ, Dalia S. Cigarette smoking is associated with a small increase in the incidence of non-Hodgkin lymphoma: a meta-analysis of 24 observational studies. Leuk Lymphoma. 2012 Oct; 53(10):1911-9. PMID: 22397720.
      Citations: 7     Fields:    Translation:Humans
    217. Castillo JJ, Furman M, Bibas M, Bower M, Chen W, Liu JJ, Miranda RN, Montoto S, Nanaji NM, Seegmiller AC, Vose JM, Beltr?n BE, D?ez-Mart?n JL, Navarro JT. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer. 2012 Nov 01; 118(21):5270-7. PMID: 22510767.
      Citations: 44     Fields:    Translation:Humans
    218. Castillo JJ, Mull N, Reagan JL, Nemr S, Mitri J. Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies. Blood. 2012 May 24; 119(21):4845-50. PMID: 22496152; PMCID: PMC3367891.
      Citations:    
    219. Reagan JL, Castillo JJ. Why is my patient neutropenic? Hematol Oncol Clin North Am. 2012 Apr; 26(2):253-66, vii. PMID: 22463826.
      Citations: 2     Fields:    Translation:Humans
    220. Beltran BE, Morales D, Quinones P, Miranda RN, Goswami M, Castillo JJ. Peripheral T-cell lymphoma with a regulatory T-cell phenotype: report of a nodal and an extranodal case from Peru. Appl Immunohistochem Mol Morphol. 2012 Mar; 20(2):196-200. PMID: 21836498.
      Citations: 2     Fields:    Translation:HumansCells
    221. Winer ES, Ingham RR, Castillo JJ. PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Mar; 21(3):355-61. PMID: 22300471.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    222. Castillo JJ, Echenique IA. Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies. Am J Hematol. 2012 Mar; 87(3):330-3. PMID: 22308010.
      Citations: 8     Fields:    Translation:Humans
    223. Bishop KD, Castillo JJ. Risk factors associated with Clostridium difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia. Leuk Lymphoma. 2012 Aug; 53(8):1617-9. PMID: 22221036.
      Citations: 9     Fields:    Translation:HumansCells
    224. Castillo JJ, Reagan JL, Ingham RR, Furman M, Dalia S, Merhi B, Nemr S, Zarrabi A, Mitri J. Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies. Leuk Res. 2012 Jul; 36(7):868-75. PMID: 22285508.
      Citations: 34     Fields:    Translation:Humans
    225. Castillo JJ, Beltran BE, Song MK, Ilic I, Leppa S, Nurmi H, Seki R, Uccella S, Li JM, Treaba DO, Stachurski D, Butera JN. The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2012 Apr; 36(4):413-7. PMID: 22277681.
      Citations: 20     Fields:    Translation:Humans
    226. Castillo JJ, Furman M, Winer ES. CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs. 2012 Jan; 21(1):15-22. PMID: 22112004.
      Citations: 30     Fields:    Translation:Humans
    227. Beltran BE, Morales D, Revilla JC, Alva JC, Castillo JJ, Qui?ones P. Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriers. Leuk Res Treatment. 2012; 2012:262363. PMID: 23198156; PMCID: PMC3505915.
      Citations: 5     
    228. Castillo JJ, Dalia S, Shum H. Meta-analysis of the association between cigarette smoking and incidence of Hodgkin's Lymphoma. J Clin Oncol. 2011 Oct 10; 29(29):3900-6. PMID: 21911724.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    229. Beltran BE, Morales D, Medeiros LJ, Miranda RN, Castillo JJ, Qui?ones P. EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals. Clin Lymphoma Myeloma Leuk. 2011 Dec; 11(6):512-6. PMID: 21889434.
      Citations: 21     Fields:    Translation:Humans
    230. Beltran BE, Castillo JJ, Morales D, de Mendoza FH, Quinones P, Miranda RN, Gallo A, Lopez-Ilasaca M, Butera JN, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: a case series from Peru. Am J Hematol. 2011 Aug; 86(8):663-7. PMID: 21761432.
      Citations: 19     Fields:    Translation:HumansCells
    231. Castillo JJ, Sinclair N, Stachurski D, Jacobsen ED. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis. Am J Hematol. 2011 Aug; 86(8):690-3. PMID: 21630306.
      Citations:    Fields:    Translation:HumansCells
    232. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin GA, Butera JN. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011 Apr; 11(2):185-9. PMID: 21575922.
      Citations: 31     Fields:    Translation:Humans
    233. Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. ScientificWorldJournal. 2011 Mar 22; 11:687-96. PMID: 21442146; PMCID: PMC5720057.
      Citations: 45     Fields:    Translation:Humans
    234. Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F, Horwitz SM, Montoto S, Pantanowitz L, Ribera JM, Vose JM. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011 Mar; 86(3):256-61. PMID: 21328430.
      Citations: 14     Fields:    Translation:Humans
    235. Reagan JL, Castillo JJ. Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2011 Feb; 11(2):151-60. PMID: 21342032.
      Citations: 4     Fields:    Translation:Humans
    236. Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist. 2011; 16(1):87-96. PMID: 21212426; PMCID: PMC3228047.
      Citations: 23     Fields:    Translation:HumansCells
    237. Beltran BE, Castillo JJ, Salas R, Morales D, Cotrina E, Miranda RN, Sotomayor EM, Qui?ones P. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America. Leuk Lymphoma. 2011 Jan; 52(1):153-6. PMID: 21219127.
      Citations: 1     Fields:    Translation:HumansCells
    238. Berz D, Castillo JJ, Quilliam DN, Colvin G. Pesticides and non-Hodgkin lymphoma: an overview for the clinician. Med Health R I. 2011 Jan; 94(1):10-2. PMID: 21290988.
      Citations:    Fields:    Translation:Humans
    239. Wang CC, Castillo JJ. Management of HIV-associated lymphomas. Med Health R I. 2011 Jan; 94(1):4-6. PMID: 21290986.
      Citations: 1     Fields:    Translation:Humans
    240. Castillo JJ, Rizack T, Treaba D. Immunophenotypical Switch versus Tumor Heterogeneity in a Patient with HIV-Associated Diffuse Large B-Cell Lymphoma. Patholog Res Int. 2010 Oct 05; 2011:563216. PMID: 21151539; PMCID: PMC2989698.
      Citations: 2     
    241. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010 Nov; 51(11):2047-53. PMID: 20919850.
      Citations: 54     Fields:    Translation:HumansCells
    242. Castillo JJ, Morales D, Quinones P, Cotrina E, Desposorio C, Beltran B. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma. 2010 Oct; 51(10):1822-8. PMID: 20849388.
      Citations: 14     Fields:    Translation:Humans
    243. Layton JL, Castillo JJ. Non-AIDS defining cancers. Med Health R I. 2010 Oct; 93(10):296-8. PMID: 21284267.
      Citations:    
    244. Beltran B, Morales D, Cotrina E, Castillo JJ, Qui?ones P. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leuk Res. 2011 Mar; 35(3):334-9. PMID: 20828817.
      Citations: 8     Fields:    Translation:Humans
    245. Castillo JJ, Dalia S, Pascual SK. Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood. 2010 Oct 21; 116(16):2897-907. PMID: 20625008.
      Citations: 23     Fields:    Translation:Humans
    246. Mazzaglia PJ, Strenger R, Castillo JJ. Extramedullary relapse of acute myeloid leukemia in a surgical wound. Leuk Lymphoma. 2011 Mar; 52(3):541-3. PMID: 20593978.
      Citations:    Fields:    Translation:Humans
    247. Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma. Oncologist. 2010; 15(3):293-9. PMID: 20167839; PMCID: PMC3227958.
      Citations: 39     Fields:    Translation:Humans
    CASTILLO's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (478)
    Explore
    _
    Co-Authors (9)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _